Log in

NASDAQ:MYGNMyriad Genetics News Headlines

$14.59
+0.33 (+2.31 %)
(As of 05/27/2020 04:00 PM ET)
Add
Compare
Today's Range
$13.75
Now: $14.59
$14.79
50-Day Range
$14.17
MA: $14.85
$15.92
52-Week Range
$9.24
Now: $14.59
$48.40
Volume1.43 million shs
Average Volume1.07 million shs
Market Capitalization$1.09 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.33

Headlines

Myriad Genetics (NASDAQ MYGN) News Headlines

Source:
DateHeadline
Myriad Genetics, Inc. (NASDAQ:MYGN) Expected to Announce Earnings of -$0.36 Per ShareMyriad Genetics, Inc. (NASDAQ:MYGN) Expected to Announce Earnings of -$0.36 Per Share
www.americanbankingnews.com - May 27 at 8:17 AM
Cerecor and Myriad Genetics Announce that Levels of LIGHT, a Novel Cytokine, Were Highly Correlated with Disease Severity and Mortality in COVID-19 ARDS Biomarker StudyCerecor and Myriad Genetics Announce that Levels of LIGHT, a Novel Cytokine, Were Highly Correlated with Disease Severity and Mortality in COVID-19 ARDS Biomarker Study
finance.yahoo.com - May 26 at 8:34 AM
Myriad Genetics, Inc. (NASDAQ:MYGN) Sees Significant Drop in Short InterestMyriad Genetics, Inc. (NASDAQ:MYGN) Sees Significant Drop in Short Interest
www.americanbankingnews.com - May 21 at 6:20 PM
FDA OKs two companion diagnostics for Lynparza for prostate cancerFDA OKs two companion diagnostics for Lynparza for prostate cancer
seekingalpha.com - May 20 at 8:23 AM
FDA OKs Myriads BRACAnalysis CDx Test As Companion Diagnostics For LynparzaFDA OKs Myriad's BRACAnalysis CDx Test As Companion Diagnostics For Lynparza
www.nasdaq.com - May 20 at 8:23 AM
Myriad Receives FDA Approval of BRACAnalysis CDx® as a Companion Diagnostic for Lynparza® in HRR-mutated Metastatic Castration-Resistant Prostate CancerMyriad Receives FDA Approval of BRACAnalysis CDx® as a Companion Diagnostic for Lynparza® in HRR-mutated Metastatic Castration-Resistant Prostate Cancer
finance.yahoo.com - May 20 at 8:23 AM
Myriads (MYGN) EndoPredict Grows Amid Coronavirus MayhemMyriad's (MYGN) EndoPredict Grows Amid Coronavirus Mayhem
www.nasdaq.com - May 18 at 1:09 PM
Myriad's (MYGN) EndoPredict Grows Amid Coronavirus MayhemMyriad's (MYGN) EndoPredict Grows Amid Coronavirus Mayhem
finance.yahoo.com - May 18 at 1:09 PM
Biotech ETFs to Gain From Latest Advancements in Cancer DrugsBiotech ETFs to Gain From Latest Advancements in Cancer Drugs
finance.yahoo.com - May 13 at 6:26 PM
Myriads Ovarian Cancer Test Approved, And Other News: The Good, Bad And Ugly Of BiopharmaMyriad's Ovarian Cancer Test Approved, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - May 13 at 1:25 PM
Thinking about buying stock in Aurora Cannabis, Cytokinetics, Quotient, Myriad Genetics, or Avaya Holdings?Thinking about buying stock in Aurora Cannabis, Cytokinetics, Quotient, Myriad Genetics, or Avaya Holdings?
www.prnewswire.com - May 11 at 4:57 PM
FDA OKs Myriad test as companion diagnostic for Lynparza in ovarian cancerFDA OKs Myriad test as companion diagnostic for Lynparza in ovarian cancer
seekingalpha.com - May 11 at 4:57 PM
Myriad: FDA Approves MyChoice CDx Test As Companion Diagnostics For LynparzaMyriad: FDA Approves MyChoice CDx Test As Companion Diagnostics For Lynparza
www.nasdaq.com - May 11 at 8:05 AM
Myriad Genetics, Inc. (NASDAQ:MYGN) Given Average Rating of "Hold" by BrokeragesMyriad Genetics, Inc. (NASDAQ:MYGN) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - May 11 at 6:36 AM
FY2020 EPS Estimates for Myriad Genetics, Inc. Cut by SVB Leerink (NASDAQ:MYGN)FY2020 EPS Estimates for Myriad Genetics, Inc. Cut by SVB Leerink (NASDAQ:MYGN)
www.americanbankingnews.com - May 11 at 3:56 AM
Piper Sandler Weighs in on Myriad Genetics, Inc.s FY2020 Earnings (NASDAQ:MYGN)Piper Sandler Weighs in on Myriad Genetics, Inc.'s FY2020 Earnings (NASDAQ:MYGN)
www.americanbankingnews.com - May 11 at 3:56 AM
Myriad Genetics (NASDAQ:MYGN) PT Lowered to $12.00Myriad Genetics (NASDAQ:MYGN) PT Lowered to $12.00
www.americanbankingnews.com - May 6 at 6:57 PM
Edited Transcript of MYGN earnings conference call or presentation 5-May-20 8:30pm GMTEdited Transcript of MYGN earnings conference call or presentation 5-May-20 8:30pm GMT
finance.yahoo.com - May 6 at 1:46 PM
Myriad Genetics (MYGN) Lags Q3 Earnings Estimates, Cancels ViewMyriad Genetics (MYGN) Lags Q3 Earnings Estimates, Cancels View
finance.yahoo.com - May 6 at 1:46 PM
Myriad Genetics (NASDAQ:MYGN) Earns Hold Rating from Needham & Company LLCMyriad Genetics (NASDAQ:MYGN) Earns Hold Rating from Needham & Company LLC
www.americanbankingnews.com - May 6 at 11:55 AM
Myriad Genetics (NASDAQ:MYGN) PT Lowered to $14.00 at Piper SandlerMyriad Genetics (NASDAQ:MYGN) PT Lowered to $14.00 at Piper Sandler
www.americanbankingnews.com - May 6 at 7:41 AM
Zacks: Brokerages Expect Myriad Genetics, Inc. (NASDAQ:MYGN) Will Post Quarterly Sales of $163.66 MillionZacks: Brokerages Expect Myriad Genetics, Inc. (NASDAQ:MYGN) Will Post Quarterly Sales of $163.66 Million
www.americanbankingnews.com - May 6 at 3:24 AM
Myriad Genetics, Inc. (MYGN) CEO Bryan Riggsbee on Q3 2020 Results - Earnings Call TranscriptMyriad Genetics, Inc. (MYGN) CEO Bryan Riggsbee on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - May 5 at 11:36 PM
Myriad Genetics Inc (MYGN) Q3 2020 Earnings Call TranscriptMyriad Genetics Inc (MYGN) Q3 2020 Earnings Call Transcript
www.fool.com - May 5 at 11:06 PM
Myriad Genetics (NASDAQ:MYGN) Posts Quarterly  Earnings Results, Misses Expectations By $0.10 EPSMyriad Genetics (NASDAQ:MYGN) Posts Quarterly Earnings Results, Misses Expectations By $0.10 EPS
www.americanbankingnews.com - May 5 at 9:08 PM
Myriad Genetics Posts Adj. Loss In Q3Myriad Genetics Posts Adj. Loss In Q3
www.finanznachrichten.de - May 5 at 6:23 PM
Myriad Genetics EPS misses by $0.09, misses on revenueMyriad Genetics EPS misses by $0.09, misses on revenue
seekingalpha.com - May 5 at 6:23 PM
Myriad Genetics Posts Adj. Loss In Q3 - Quick FactsMyriad Genetics Posts Adj. Loss In Q3 - Quick Facts
www.nasdaq.com - May 5 at 6:23 PM
Myriad Genetics Reports Fiscal Third-Quarter 2020 Financial ResultsMyriad Genetics Reports Fiscal Third-Quarter 2020 Financial Results
finance.yahoo.com - May 5 at 6:23 PM
Investors Buy Large Volume of Put Options on Myriad Genetics (NASDAQ:MYGN)Investors Buy Large Volume of Put Options on Myriad Genetics (NASDAQ:MYGN)
www.americanbankingnews.com - May 5 at 7:21 AM
Myriad Genetics Q3 2020 Earnings PreviewMyriad Genetics Q3 2020 Earnings Preview
seekingalpha.com - May 4 at 10:18 PM
Noteworthy Monday Option Activity: MYGN, GS, BGSNoteworthy Monday Option Activity: MYGN, GS, BGS
www.nasdaq.com - May 4 at 5:18 PM
$0.01 EPS Expected for Myriad Genetics, Inc. (NASDAQ:MYGN) This Quarter$0.01 EPS Expected for Myriad Genetics, Inc. (NASDAQ:MYGN) This Quarter
www.americanbankingnews.com - May 4 at 11:30 AM
Myriad to Announce Fiscal Third-Quarter 2020 Financial Results on May 5, 2020Myriad to Announce Fiscal Third-Quarter 2020 Financial Results on May 5, 2020
finance.yahoo.com - April 28 at 6:22 PM
Myriad Genetics, Inc. (MYGN), Overstock.com, Inc. (OSTK) & Waitr Holdings Inc. (WTRH) - Bronstein, Gewirtz & Grossman, LLCMyriad Genetics, Inc. (MYGN), Overstock.com, Inc. (OSTK) & Waitr Holdings Inc. (WTRH) - Bronstein, Gewirtz & Grossman, LLC
www.bloomberg.com - April 27 at 7:18 AM
Myriad Genetics Announces Publication of a Meta-Analysis Demonstrating the Clinical Utility of the GeneSight® Psychotropic Test in People with Major Depressive DisorderMyriad Genetics Announces Publication of a Meta-Analysis Demonstrating the Clinical Utility of the GeneSight® Psychotropic Test in People with Major Depressive Disorder
finance.yahoo.com - April 20 at 7:15 AM
Daily roundup of COVID-19 activities/initiatives - healthcareDaily roundup of COVID-19 activities/initiatives - healthcare
seekingalpha.com - April 8 at 8:56 AM
Myriad Genetics Withdraws FY20 Outlook Amid COVID-19 - Quick FactsMyriad Genetics Withdraws FY20 Outlook Amid COVID-19 - Quick Facts
www.nasdaq.com - April 8 at 8:56 AM
Myriad Genetics (MYGN) BRACAnalysis Gets Japan ReimbursementMyriad Genetics' (MYGN) BRACAnalysis Gets Japan Reimbursement
finance.yahoo.com - April 8 at 8:56 AM
Myriad Genetics pulls guidance - roundup of COVID-19 healthcare newsMyriad Genetics pulls guidance - roundup of COVID-19 healthcare news
seekingalpha.com - April 8 at 8:56 AM
Myriad Withdrawing Financial Guidance for FY2020 Due to Business Impact from Coronavirus PandemicMyriad Withdrawing Financial Guidance for FY2020 Due to Business Impact from Coronavirus Pandemic
finance.yahoo.com - April 8 at 8:56 AM
Myriad Genetics' (MYGN) BRACAnalysis Gets Japan ReimbursementMyriad Genetics' (MYGN) BRACAnalysis Gets Japan Reimbursement
finance.yahoo.com - April 7 at 5:00 PM
Hedge Funds Are Buying Myriad Genetics, Inc. (MYGN)Hedge Funds Are Buying Myriad Genetics, Inc. (MYGN)
finance.yahoo.com - April 7 at 5:00 PM
Myriad Receives Reimbursement for the BRACAnalysis® Diagnostic System in Japan for Patients with Breast or Ovarian Cancer Associated with HBOCMyriad Receives Reimbursement for the BRACAnalysis® Diagnostic System in Japan for Patients with Breast or Ovarian Cancer Associated with HBOC
finance.yahoo.com - April 6 at 7:22 AM
Myriad Genetics seeks expanded use of BRACAnalysis in JapanMyriad Genetics seeks expanded use of BRACAnalysis in Japan
seekingalpha.com - March 30 at 5:05 PM
Myriad Files Application In Japan To Expand Indications For BRACAnalsyisMyriad Files Application In Japan To Expand Indications For BRACAnalsyis
www.nasdaq.com - March 30 at 8:35 AM
Myriad Seeks Japanese Regulatory Approval for its BRACAnalysis® Diagnostic System in People with Advanced Pancreatic and Prostate CancerMyriad Seeks Japanese Regulatory Approval for its BRACAnalysis® Diagnostic System in People with Advanced Pancreatic and Prostate Cancer
finance.yahoo.com - March 30 at 8:35 AM
Myriad Announces Board of Directors Leadership TransitionMyriad Announces Board of Directors Leadership Transition
finance.yahoo.com - March 23 at 10:41 AM
A Look At The Intrinsic Value Of Myriad Genetics, Inc. (NASDAQ:MYGN)A Look At The Intrinsic Value Of Myriad Genetics, Inc. (NASDAQ:MYGN)
finance.yahoo.com - March 23 at 10:41 AM
Genetic Testing Stocks Rise Again as Volatility ContinuesGenetic Testing Stocks Rise Again as Volatility Continues
www.fool.com - March 19 at 6:16 PM
This page was last updated on 5/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.